Imagen de Portada

Associations of short‐term changes in obesity indices with all‐cause mortality and cardiovascular disease

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Lyu Wang, Yun‐Yang Deng, Tsung Yu, Xiang‐Qian Lao, Martin C. S. Wong
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Obesity
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Association of body roundness index with cardiovascular disease and all‐cause mortality among Chinese adults
por: Hong Lin, et al.
Publicado: (2025)

Association of metabolic score for visceral fat with all‐cause mortality, cardiovascular mortality, and cancer mortality: A prospective cohort study
por: Shanshan Jia, et al.
Publicado: (2024)

Association of cumulative exposure to cholesterol, high‐density lipoprotein, and glucose index with the risk of cardiovascular disease and all‐cause mortality: A longitudinal cohort study
por: Ruobing Tian, et al.
Publicado: (2025)

Cardiovascular autonomic dysfunction precedes cardiovascular disease and all‐cause mortality: 11‐year follow‐up in the ADDITION ‐ PRO study
por: Jonas R. Schaarup, et al.
Publicado: (2025)

Associations of relative fat mass and BMI with all‐cause mortality: Confounding effect of muscle mass
por: Navin Suthahar, et al.
Publicado: (2024)

Associations between Chinese visceral adiposity index and risks of all‐cause and cause‐specific mortality: A population‐based cohort study
por: Xiaoyan Wu, et al.
Publicado: (2024)

Biological aging mediates the associations of metabolic score for insulin resistance with all‐cause and cardiovascular disease mortality among US adults: A nationwide cohort study
por: Xiaoxuan Li, et al.
Publicado: (2024)

Impact of time in tight range on all‐cause and cardiovascular mortality in type 2 diabetes: A prospective cohort study
por: Jinghao Cai, et al.
Publicado: (2025)

Longitudinal exposure to non‐ HDL ‐C and cardiovascular events, all‐cause mortality in type 2 diabetes: A post hoc analysis of the ACCORD trial
por: Yueyue Wang, et al.
Publicado: (2026)

Long‐term all‐cause mortality of metabolic‐dysfunction associated steatotic liver disease based on body weight phenotypes following acute myocardial infarction: A retrospective cohort study
por: Jaycie Koh, et al.
Publicado: (2024)

Risk acceleration by gout on major adverse cardiovascular events and all‐cause death in patients with diabetes and chronic kidney disease
por: Da Young Lee, et al.
Publicado: (2025)

Sex‐specific associations between haemoglobin glycation index and the risk of cardiovascular and all‐cause mortality in individuals with pre‐diabetes and diabetes: A large prospective cohort study
por: Jingqi Yang, et al.
Publicado: (2024)

Low serum 1,5‐anhydroglucitol is associated with increased risk of all‐cause and cardiovascular mortality in type 2 diabetes: A real‐world cohort study
por: Jiaying Ni, et al.
Publicado: (2025)

Estimating the risk of cardiovascular outcomes and all‐cause mortality in individuals with type 2 diabetes: Validation of the UKPDS outcomes model using TECOS and EXSCEL data
por: Ruth L. Coleman, et al.
Publicado: (2025)

Metabolic bariatric surgery is associated with reduced adverse hepatic and extrahepatic outcomes, and lower all‐cause mortality, in patients with steatotic liver disease
por: Weronika Stupalkowska, et al.
Publicado: (2025)

Lack of evidence for obesity paradox in patients with cardiovascular disease: A UK BioBank cohort study
por: Wenhao Yu, et al.
Publicado: (2025)

Brain structure differences in pediatric obesity: cause or consequence?
por: Susan Carnell
Publicado: (2024)

Continuous glucose monitoring and all‐cause mortality in insulin‐using population with diabetes and cognitive impairment
por: Pareeta Kotecha, et al.
Publicado: (2024)

Does deciding not to participate in a lifestyle intervention for children with obesity affect the long‐term weight change?
por: Rasmus M. Jørgensen, et al.
Publicado: (2025)

Association of obesity or metabolic syndrome with various allergic diseases: An overview of reviews
por: Yasutaka Kuniyoshi, et al.
Publicado: (2024)

Graded association of muscle strength with all‐cause and cause‐specific mortality in older adults with diabetes: Prospective cohort study across 28 countries
por: Lars Louis Andersen, et al.
Publicado: (2024)

Unraveling the obesity paradox in polytrauma patients: survival benefit specifically in individuals with obesity class I
por: Hui‐Tzung Luh, et al.
Publicado: (2025)

Trends in educational inequalities in obesity‐attributable mortality in England and Wales, Finland, and Italy
por: Fanny Janssen, et al.
Publicado: (2025)

Association of gestational diabetes with long‐term risk of premature mortality, and cardiovascular outcomes and risk factors: A retrospective cohort analysis in the UK Biobank
por: Moscho Michalopoulou, et al.
Publicado: (2024)

Association of GLP1 ‐receptor agonist use with liver disease progression, major cardiovascular events, and mortality in people with hepatic steatosis and diabetes
por: Suleiman Al Ashi, et al.
Publicado: (2025)

Modification of the association between obesity phenotypes and cardiovascular disease by social determinants of health: A prospective cohort study
por: Qiujin Huang, et al.
Publicado: (2026)

Disruption of Ephb1 causes reduced hypothalamic CRH and TRH expression and obesity in mice
por: Simin Xie, et al.
Publicado: (2025)

BMI and mortality in critically ill patients with COVID‐19: another brick in the wall of the obesity paradox
por: Amanda Vilaverde Perez, et al.
Publicado: (2024)

Correction to “Lack of evidence for obesity paradox in patients with cardiovascular disease: A UK BioBank cohort study”
Publicado: (2025)

Association of overweight/obesity and overweight/obesity‐related metabolic dysfunction‐associated steatotic liver disease in young adults with coronary artery calcification later in life
por: Jia‐Jie Wang, et al.
Publicado: (2024)

Association of normal range of urinary albumin‐to‐creatinine ratio with all‐cause mortality among diabetic adults with preserved kidney function: National Health and Nutrition Examination Survey ( NHANES ) 2003–2018
por: Xiaoxia Pang, et al.
Publicado: (2025)

Trends in mortality and hospitalisations for cardiovascular, kidney and liver disease in people with type 2 diabetes in England, 2009–2019
por: Naomi Holman, et al.
Publicado: (2025)

Association between the changes in the estimated glucose disposal rate and new‐onset cardiovascular disease in middle‐aged and elderly individuals: A nationwide prospective cohort study in China
por: Lunqing Yan, et al.
Publicado: (2025)

Associations between obesity and severity of coronavirus disease 2019 in Brazilian inpatients: A 2021 secondary data analysis
por: Gabrielle Ribeiro Sena, et al.
Publicado: (2024)

Maternal folic acid supplementation during pregnancy in association with childhood overweight or obesity
por: Chi‐Yen Hung, et al.
Publicado: (2024)

Prevalence of obesity and cardiovascular disease in adults with type 2 diabetes and use of diabetes medication in Germany: A claims data study
por: Nora Hennies, et al.
Publicado: (2024)

Degree of joint risk factor control and incident chronic kidney disease among individuals with obesity
por: Rui Tang, et al.
Publicado: (2024)

Glucagon‐like peptide‐1 receptor agonists lower risk of cardiovascular and non‐cardiovascular mortality: A meta‐analysis of eleven cardiovascular outcome trials
por: Yu Mi Kang, et al.
Publicado: (2025)

Metabolomics: Implication in cardiovascular research and diseases
por: Amir Ajoolabady, et al.
Publicado: (2024)

The critical role of abdominal obesity as a crucial cardiovascular risk factor
por: Salvatore Corrao, et al.
Publicado: (2024)